Highline Capital Management’s Moderna MRNA Stock Holding History

Highline Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell
2020 Q1	$7.49M	Buy
2019 Q4	$2.93M	Buy
2019 Q2	–	Sell
2019 Q1	$18.9M	Sell
2018 Q4	$23.2M	Buy